Morepen Laboratories Ltd share price logo

Morepen Laboratories Ltd

NSE: MOREPENLAB

BSE: 500288

Small Cap

Pharma Sector

₹113.35

-5.96

(-5.00%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Morepen Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-17%

Searches for Morepen Laboratories on INDmoney have decreased by 17% over the last 30 days.

Investment activity on INDmoney

-20.91%

Investment activity in Morepen Laboratories among INDmoney users has decreased by 20.91% over the last 30 days.

Among the most traded stocks

262nd

Morepen Laboratories was the 262nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

29 days

INDmoney investors hold Morepen Laboratories shares for an average of 29 days.

Key Events for Morepen Laboratories

Last Dividend Declared

₹0.20 per share, declared on 26/05/2026

View Dividend History

Morepen Laboratories Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • Day's High

    ₹113.35
    ₹122.23

    7.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹33.05
    ₹150.70
    downward going graph

    70.84%

    Downside

    32.95%

    Upside

    downward going graph

Morepen Laboratories share price movements today

Previous Close
₹119.31
Open
₹113.35
Volume
88.58L
Upper Circuit
₹125.27
Lower Circuit
₹113.35
Day's Low - High
₹113.35 - ₹122.23
52 Week Low - High
₹33.05 - ₹150.70

Morepen Laboratories Historical Returns

1 Month Return
-10.78 %
3 Month Return
+ 109.17 %
1 Year Return
+ 150.76 %
3 Year Return
+ 257.75 %
5 Year Return
+ 137.67 %

Morepen Laboratories Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹6,211.06 Cr

Return on Equity (ROE)

5.45

PE Ratio (TTM)

34.78

Return on capital employed (ROCE)

7.2

Industry PE ratio

51.65

Beta (LTM)

1.24

P/B Ratio

1.49

Dividend Yield

0.59

PEG Ratio

21.21

Quarterly Earnings Growth YOY

116.59

EPS (TTM)

1.75

Book Value

22.75

Morepen Laboratories Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Morepen Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (10.48x)

March 23, 2020

Today (34.78x)

October 29, 2026

Industry (51.65x)

October 29, 2026

Highest (64.70x)

January 22, 2018

LowHigh

Today’s Price to Earnings Ratio: 34.78x

Morepen Laboratories Technical Analysis

Track how Morepen Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish4
Bullish2
Neutral9

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
666.67
Bearish
RSI (14)
47.2
Neutral
Momentum (10)
0
Neutral
ADI (14)
81.67
Neutral
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
113.35
Neutral
EMA (20)
113.35
Neutral
VWMA (20)
113.35
Neutral
SMA (50)
113.35
Neutral
EMA (50)
113.35
Bearish
SMA (200)
113.35
Neutral
EMA (200)
113.53
Bearish
KAMA (200)
113.35
Neutral
DEMA (200)
112.9
Bullish

Morepen Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Morepen Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Morepen Laboratories Ltd image
Morepen Laboratories Ltd
NA6,211.0627.53%0.58951,805
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
BUY703.856.04%0.6229235
Coral Laboratories Ltd image
Coral Laboratories Ltd
NA172.918.06%0.001685
Vasundhara Rasayans Ltd image
Vasundhara Rasayans Ltd
NA41.35-0.31%0.00535
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA137.0817.94%0.004105
See all

Morepen Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
444.55
423.07
455.22
437.73
452.78
465.85
425.24
411.58
484.16
484.72
570.13
746.5
Other Income
4.07
4.24
3.43
4.99
5.34
4.61
4.41
30.46
3.81
8.46
5.18
8.69
Total Income
448.62
427.32
458.64
442.71
458.12
470.46
429.65
442.04
487.97
493.18
575.31
755.19
Expenses
393.99
374.69
403.6
393.66
416.64
423.61
401.07
380.88
437.84
460.27
487.59
623.39
Operating Profit
50.56
48.38
51.62
44.07
36.14
42.24
24.17
30.7
46.32
24.45
82.54
123.11
Operating Profit Margin %
11.37%
11.44%
11.34%
10.07%
7.98%
9.07%
5.68%
7.46%
9.57%
5.04%
14.48%
16.49%
Profit Before Interest, Tax and Depreciation
54.64
52.62
55.05
49.06
41.48
46.85
28.58
61.16
50.12
32.91
87.72
131.8
Interest
2.17
0.8
1.15
1.18
1.34
4.67
4.04
4.18
4.32
3.88
4.84
5.19
Depreciation
8.45
9.62
5.73
1.86
4.93
16.47
9.03
11.28
10.38
5.75
8.35
10.07
Profit Before Tax
44.02
42.2
48.17
46.02
35.21
25.71
15.51
45.7
35.42
23.28
74.53
116.54
Tax Paid
12.03
13.46
12
11.17
8.52
5.41
4.11
4.65
7.93
7.59
18.18
27.65
Profit After Tax
31.99
28.74
36.17
34.85
26.69
20.31
11.41
41.04
27.5
15.7
56.35
88.89
Total Net profit including share of profit / Loss from associate company
31.99
28.74
36.17
34.85
26.69
20.31
11.41
41.04
27.5
15.7
56.35
88.89
EPS
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
1.62
Actual EPS
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
1.62
Adjusted EPS
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
1.62
Diluted EPS
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
1.62

Morepen Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
606.51
768.54
853.07
1,188.06
1,546.83
1,417.53
1,690.43
1,811.58
1,805.69
Other Income
3.72
3.67
9.48
12.07
10.31
6.13
13.97
18.36
47.14
Total Income
610.23
772.21
862.55
1,200.13
1,557.13
1,423.66
1,704.4
1,829.94
1,852.83
Expenses
541.96
701.02
784.55
1,069.54
1,410.15
1,338
1,531.81
1,637.51
1,680.06
Operating Profit
64.55
67.52
68.52
118.52
136.68
79.53
158.62
174.07
125.63
Operating Profit Margin %
10.64%
8.79%
8.03%
9.98%
8.84%
5.61%
9.38%
9.61%
6.96%
Profit Before Interest, Tax and Depreciation
68.27
71.19
78
130.58
146.98
85.67
172.6
192.43
172.77
Interest
4.36
2.11
1.98
1.79
-7.37
1.98
3.71
8.34
16.41
Depreciation
34.32
39.9
36.91
30.28
27.64
27.93
33.47
28.98
36.43
Profit Before Tax
29.59
29.18
39.11
98.51
126.71
55.76
135.42
155.11
119.93
Tax Paid
-
0.34
5.53
1.42
25.02
17.08
38.79
37.1
24.28
Profit After Tax
29.59
28.84
33.58
97.09
101.68
38.68
96.62
118.02
95.65
Total Net profit including share of profit / Loss from associate company
29.59
28.84
33.58
97.09
101.68
38.68
96.62
118.02
95.65
EPS
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
1.73
Actual EPS
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
1.73
Adjusted EPS
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
1.73
Diluted EPS
0.66
0.64
0.75
2.15
1.96
0.77
1.88
2.2
1.73

Morepen Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
50.07
40.73
63.41
17.37
11.02
50.83
-60.24
-91.17
73.37
32.06
32.64
Cash Flow from Investing Activities
-27.3
-13.6
-26.92
-13.05
-12.46
-70.35
-31.68
-46.51
-83.31
-321.51
-126.24
Cash Flow from Financing Activities
-27.26
-23.72
-37.78
-0.44
5.49
47.26
66.33
143.54
5.2
299.88
97.41
Net Cash Flow
-4.49
3.4
-1.29
3.88
4.04
27.75
-25.58
5.86
-4.72
10.44
3.81

Morepen Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
38.22%
38.22%
38.22%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
DII
2%
2.15%
2.15%
2.9%
1.7%
1.64%
1.68%
1.51%
1.5%
1.25%
1.25%
1.28%
1.71%
FII
0%
1.85%
1.67%
7.72%
2.08%
2.22%
1.94%
1.72%
1.62%
1.62%
1.58%
1.46%
3.43%
Government
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
57.44%
57.77%
57.95%
53.72%
60.56%
60.47%
60.72%
61.11%
61.21%
61.46%
61.5%
61.59%
59.19%
Total Outstanding Shares
51,11,68,708
51,11,68,708
51,11,68,708
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
Total Shareholders
3,04,289
3,36,019
3,48,766
3,52,839
4,30,929
4,48,361
4,68,860
4,61,180
4,61,853
4,53,137
4,47,286
4,34,912
4,03,932

Mutual Funds Buying / Exiting Morepen Laboratories

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Morepen Laboratories

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Morepen Laboratories

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.05 Cr

₹0.00 Cr (-6.54%)

0.27%

Morepen Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Morepen Laboratories.

  • Morepen Laboratories Ltd Earnings Results

    Morepen Laboratories Ltd’s net profit jumped 117.49% since last year same period to ₹88.89Cr in the Q2 2026-2027. On a quarterly growth basis, Morepen Laboratories Ltd has generated 57.61% jump in its net profits since last 3-months.

    Read More

  • Morepen Laboratories Ltd Dividends May,2026

    In the quarter ending March 2026, Morepen Laboratories Ltd has declared dividend of ₹0.20 per share on 26 May 2026 - translating a dividend yield of 0.17%.

    Read More about Dividends

Indices Featuring Morepen Laboratories Stock

Check stock indices that include Morepen Laboratories.

BSE Healthcare

₹50,168.37

+474.08 (▲0.95%)

Insights on Morepen Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MOREPENLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.46% to 3.43% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 15.74 Cr → 88.89 Cr (in ₹), with an average increase of 54.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 429.65 Cr → 755.19 Cr (in ₹), with an average increase of 10.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 35.65% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 520.3% return, outperforming this stock by 262.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MOREPENLAB stock has moved down by -5.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 61.59% to 59.19% in Sep 2026 quarter

About Morepen Laboratories Ltd

Morepen Laboratories Limited is a pharmaceutical company based in India that develops and markets formulation products in numerous therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic, and neuropsychiatry. Their products include Loratadine Montelukast Sodium, Atorvastatin Calcium and Sultamicillin, along with new entries such as Kilbac Ducal, D Aclomore and Montelast-L. It currently has three state-of-the-art manufacturing plants in Himachal Pradesh, India, with the main plant in Parwanoo being USFDA-approved for Loratadine production. The company was established in 1984 and since then has filed 14 patents, including an international one on a new amorphous form of Lipitor Atorvastatin. Expansion plans from 1992-1993 saw the installation of bulk drugs from 162 MT to 245 MT and the launch of two new molecules – Ketrolac, Tromethamine and Omeprazole. In 1995-1996, the company increased bulk drug installation from 305 MT to 469 MT and launched Loratadine and Cisapride. The year 1996-1997 saw the commencement of their own formulation unit, while they filed an international patent on a new amorphous form of Atorvastatin, world’s largest selling drug in 2000-2001. In 2001-2002, their drug and drug intermediate installation reached 1251 MT, with the launch of a number of contemporary lifestyle and self-medication products. Their joint venture with DiaMed AG of Switzerland was among the highlights of the year 2004-2005, while 2006-2007 saw them acquire fifty new prospective customers in Korea, Japan and Taiwan. The year 2007-2008 was marked by the company making tie-ups with several new business segments, along with marketing alliances with global players such as Immucor USA, Teco Medical Instruments, and In-Tech, INC.

Revenue: ₹746.50Cr as on September 2026 (Q2 FY27)
Net Profit: ₹88.89Cr as on September 2026 (Q2 FY27)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
OrganisationMorepen Laboratories Ltd
HeadquartersGurgaon
IndustryPharmaceuticals
CEOSushil Suri
E-voting on sharesClick here to vote

FAQs

What is Morepen Laboratories share price today?

Morepen Laboratories share price today stands at ₹113.35 as on at the close of the market. Morepen Laboratories share today touched a day high of ₹122.23 and a low of ₹113.35.

What is the 52 week high and 52 week low range for Morepen Laboratories share?

Morepen Laboratories touched a 52 week high of ₹150.7 and a 52 week low of ₹33.05. Morepen Laboratories share price today i.e. is closed at ₹113.35, which is -24.78% down from its 52 week high and 242.97% up from its 52 week low.

What is Morepen Laboratories's market capitalisation today?

Morepen Laboratories market capitalisation is ₹6,211.06 Cr as on .

How to buy Morepen Laboratories shares?

To buy Morepen Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MOREPENLAB or Morepen Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Morepen Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Morepen Laboratories trading volume today?

Morepen Laboratories trading volume is 88.58L as on . This means that 88.58L shares of Morepen Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Morepen Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Morepen Laboratories have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 29 days. This reflects platform activity only and is not investment advice.